ArticleFrontiers in oncology2022

Comparison of endocrine therapy and chemotherapy as different systemic treatment modes for metastatic luminal HER2-negative breast cancer patients -A retrospective study.

Qiuyue Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.